Bibliographic Info
GuidelineConsolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year of Publication2021
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Moderate
When cryptococcal antigen screening is not available, fluconazole primary prophylaxis may be considered at a higher CD4 cell count threshold of < 200 cells/mm3
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children, March 2018: supplement to the 2016 consolidated guidelines of the use of antiretroviral drugs for treating and preventing HIV infection
Year2018
InstitutionWorld Health Organization
Guideline
Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV.
Year2022
InstitutionWorld Health Organization
Guideline
WHO guidelines on the management of advanced HIV disease
Year2025
InstitutionWorld Health Organization